Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FRC
First Republic Bank
FRC
|
+$734M |
| 2 |
Boeing
BA
|
+$493M |
| 3 |
Pfizer
PFE
|
+$478M |
| 4 |
UnitedHealth
UNH
|
+$440M |
| 5 |
Honeywell
HON
|
+$364M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.05B |
| 2 |
Advanced Micro Devices
AMD
|
+$447M |
| 3 |
TSMC
TSM
|
+$441M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 5 |
ExxonMobil
XOM
|
+$321M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.34% |
| 2 | Technology | 16.84% |
| 3 | Consumer Discretionary | 12.66% |
| 4 | Industrials | 10.11% |
| 5 | Consumer Staples | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LTRPA
2751
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $637K | ﹤0.01% |
740,984
-100,415
| -12% | -$110K |
|
2752
First Trust North American Energy Infrastructure Fund
EMLP
$4.11B
| $636K | ﹤0.01% |
+23,900
| New | +$643K |
|
|
MAPS
2753
DELISTED
WM TECHNOLOGY INC A
MAPS
| $636K | ﹤0.01% |
748,600
+77,100
| +11% | +$82.9K |
|
2754
Vanguard Total Bond Market
BND
$157B
| $635K | ﹤0.01% |
8,600
-78,000
| -90% | -$5.71M |
|
2755
Bolt Biotherapeutics
BOLT
$7.67M
| $635K | ﹤0.01% |
22,837
+760
| +3% | +$22.2K |
|
|
KALV
2756
DELISTED
KalVista Pharmaceuticals
KALV
| $634K | ﹤0.01% |
80,600
-13,700
| -15% | -$102K |
|
2757
ImmuCell
ICCC
$99.4M
| $633K | ﹤0.01% |
122,827
-2,662
| -2% | -$17.3K |
|
2758
Veru
VERU
$36.1M
| $633K | ﹤0.01% |
54,594
+46,200
| +550% | +$1.87M |
|
2759
iShares US Oil Equipment & Services ETF
IEZ
$355M
| $632K | ﹤0.01% |
32,700
+20,600
| +170% | +$439K |
|
2760
Hennessy Advisors
HNNA
$78.2M
| $630K | ﹤0.01% |
81,275
-1,550
| -2% | -$13.6K |
|
2761
IBEX
IBEX
$480M
| $630K | ﹤0.01% |
25,800
+16,200
| +169% | +$433K |
|
|
SLGC
2762
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $630K | ﹤0.01% |
+246,900
| New | +$707K |
|
2763
Andersons Inc
ANDE
$2.4B
| $628K | ﹤0.01% |
+15,200
| New | +$601K |
|
2764
Mission Produce
AVO
$1.13B
| $627K | ﹤0.01% |
56,400
+17,800
| +46% | +$208K |
|
2765
Coffee Holding Co
JVA
$19.2M
| $627K | ﹤0.01% |
335,264
-7,700
| -2% | -$16.3K |
|
|
FWDI
2766
Forward Industries Inc
FWDI
$301M
| $624K | ﹤0.01% |
55,934
+1,820
| +3% | +$21.3K |
|
2767
International General Insurance
IGIC
$1.18B
| $624K | ﹤0.01% |
75,300
+30,700
| +69% | +$254K |
|
|
JCTC
2768
Jewett-Cameron Trading
JCTC
$9.4M
| $624K | ﹤0.01% |
110,928
-1,100
| -1% | -$6.2K |
|
|
SBOW
2769
DELISTED
SilverBow Resources, Inc.
SBOW
| $624K | ﹤0.01% |
27,321
-111,655
| -80% | -$2.76M |
|
|
BFX
2770
DELISTED
BowFlex Inc.
BFX
| $623K | ﹤0.01% |
465,000
+3,200
| +0.7% | +$5.29K |
|
2771
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$19.1B
| $619K | ﹤0.01% |
12,944
+4,844
| +60% | +$228K |
|
2772
Pyxis Tankers
PXS
$49.6M
| $618K | ﹤0.01% |
125,801
+10,000
| +9% | +$52.4K |
|
|
KREF
2773
KKR Real Estate Finance Trust
KREF
$468M
| $617K | ﹤0.01% |
54,200
-97,300
| -64% | -$1.36M |
|
2774
Intellia Therapeutics
NTLA
$1.51B
| $617K | ﹤0.01% |
+16,554
| New | +$649K |
|
|
PRTK
2775
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $615K | ﹤0.01% |
242,124
-1,400
| -0.6% | -$2.77K |
|
Similar funds
Renaissance Technologies's Q1 2023 Portfolio in Review
As of Q1 2023, Renaissance Technologies held 4,600 positions worth $75.4B, up 3.1% from $73.1B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies's Q1 2023 filing shows 524 new, 1,665 increased, 1,689 reduced and 668 closed positions. Its largest new stake was Honeywell: 1,937,917 shares worth $349M. The largest sale was Apple, an estimated $1.05B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Technology and Consumer Discretionary.
- Renaissance Technologies's largest Q1 2023 buy was Honeywell: 1,937,917 shares worth $349M.
- Renaissance Technologies added most to First Republic Bank in Q1 2023, an estimated $734M increase.
- Renaissance Technologies's biggest Q1 2023 reduction was Apple, cutting an estimated $1.05B.
- Renaissance Technologies fully exited Advanced Micro Devices in Q1 2023, selling an estimated $447M.
- Renaissance Technologies's ten largest holdings make up 11% of its $75.4B portfolio in Q1 2023.
- Renaissance Technologies opened 524 new positions and closed 668 in Q1 2023.
- Renaissance Technologies's portfolio value rose 3.1% quarter-over-quarter to $75.4B.
Based on Renaissance Technologies's 13F filing for Q1 2023, filed 12 May 2023.